InvestorsHub Logo

Beek

10/12/18 7:09 PM

#22879 RE: LEX3 #22874

ACOL/MDTR run to $.05+ was early 2017. Per 10-k (Dec 17) O/S was 5,249,511,270. Per 10-q (Jun 19) total O/S was 5,524,636,434. We're seeing a record-setting volume ramp that has already spiked over what was seen in 2017 (~175M vs ~200M; set ihub chart to 2yr to see this). Only time will tell now if this level of trading is sustained for as long or longer than it was in 2017 of approx 1 month.
Way more catalysts, secured int prop/patents, and successful sales records from then to now makes this stock play much more appealing and is likely to achieve new heights (I hope) even though share count did, in fact, increase which is what I think you were asking. Note-They had to buy the patents with something. Those new shares are already open trading and did not affect restricted shares held by company.
Good company track record so far, rumors abound though (especially with this latest movement starting with a spike to 200M day), now it just needs to play out into the news, legislation, and let the markets answer.

Good luck to all, playing it as we see it.
IMO.

wine maker

10/13/18 10:51 AM

#22883 RE: LEX3 #22874

Lex3,
If Oct 17th actually means anything in Canada ie. retailers ordering the Medtainers then 5 cents is nothing. The co. says that they are the only co. approved by the Canadian govt. for labeling purposes as well as childproof packaging We could be looking at 50 cents to $1. or more.
If the co. feels confident in its business model then maybe they should remove 2 or 3 billion shares from the float, maybe more. If the big boys like Tilray, CGC. CRON, and Aurura start to order like crazy we have a real winner. Not a time to sell.
Its like having ice in the desert and you are the only person with the key to the icehouse.